Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.54 USD | -2.71% | +5.75% | +11.70% |
Mar. 18 | Fulcrum Therapeutics Appoints Patrick Horn as Chief Medical Officer | MT |
Mar. 18 | Fulcrum Therapeutics, Inc. Announces Executive Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.70% | 482M | |
+21.74% | 46.81B | |
-0.97% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.12% | 26.06B | |
-19.37% | 19.13B | |
+31.18% | 12.39B | |
-0.04% | 12.08B | |
+0.39% | 11.96B |
- Stock Market
- Equities
- FULC Stock
- News Fulcrum Therapeutics, Inc.
- Oppenheimer Adjusts Fulcrum Therapeutics Price Target to $16 From $20, Maintains Outperform Rating